WHO defined chronic eosinophilic leukemia, not otherwise specified (CEL, NOS): A contemporary series from the Mayo Clinic
Open Access
- 3 April 2020
- journal article
- letter
- Published by Wiley in American Journal of Hematology
- Vol. 95 (7), E172-E174
- https://doi.org/10.1002/ajh.25811
Abstract
No abstract availableThis publication has 9 references indexed in Scilit:
- World Health Organization‐defined eosinophilic disorders: 2019 update on diagnosis, risk stratification, and managementAmerican Journal of Hematology, 2019
- Recurrent activating STAT5B N642H mutation in myeloid neoplasms with eosinophiliaLeukemia, 2018
- A multimodality work-up of patients with HypereosinophiliaAmerican Journal of Hematology, 2018
- Bone marrow morphology is a strong discriminator between chronic eosinophilic leukemia, not otherwise specified and reactive idiopathic hypereosinophilic syndromeHaematologica, 2017
- Targeted next-generation sequencing identifies a subset of idiopathic hypereosinophilic syndrome with features similar to chronic eosinophilic leukemia, not otherwise specifiedLaboratory Investigation, 2016
- The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemiaBlood, 2016
- Predictors of survival in WHO-defined hypereosinophilic syndrome and idiopathic hypereosinophilia and the role of next-generation sequencingLeukemia, 2016
- Long-term follow-up of FIP1L1-PDGFRA-mutated patients with eosinophilia: survival and clinical outcomeLeukemia, 2012
- Chronic eosinophilic leukemia‐not otherwise specified has a poor prognosis with unresponsiveness to conventional treatment and high risk of acute transformationAmerican Journal of Hematology, 2012